ALS Reversals - Lunasin Regimen

Clinical trial NCT02709330 · COMPLETED

Trial details

NCT number

NCT02709330

Sponsor

Richard Bedlack, M.D., Ph.D.

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2016-04-01

Primary completion

2017-09-13

Enrollment

60

View on ClinicalTrials.gov